Evidence map›Paper›PMID 23799815›Full record

ReviewAnnual review of microbiology2013

The biology of the PmrA/PmrB two-component system: the major regulator of lipopolysaccharide modifications.

H Deborah Chen, Eduardo A Groisman

Abstract readReview
In one paragraph

Review in Annual review of microbiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 148 papers.

0numbers the graph read from it
0cells of the map it votes in
148citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

148 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Acquired mutations in transcriptional regulatorAntimicrobial agents and chemotherapy · 2026
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Deficiency in theMicroorganisms · 2025
    Article
  18. Article
  19. Article
  20. Article

88 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

H Deborah ChenDepartment of Microbial Pathogenesis.
Eduardo A Groisman

Funding

MOLECULAR AND STRUCTURAL BASES OF POLYMYXIN RESISTANCER01AI042236 · NIAID · YALE UNIVERSITY · PI GROISMAN, EDUARDO · 1998 to 2013
$3.0M
Howard Hughes Medical InstituteNIAID NIH HHS AI 42336NIAID NIH HHS R01 AI042236
6 · The paper itself

Abstract

The ability of gram-negative bacteria to resist killing by antimicrobial agents and to avoid detection by host immune systems often entails modification to the lipopolysaccharide (LPS) in their outer membrane. In this review, we examine the biology of the PmrA/PmrB two-component system, the major regulator of LPS modifications in the enteric pathogen Salmonella enterica. We examine the signals that activate the sensor PmrB and the targets controlled by the transcriptional regulator PmrA. We discuss the PmrA/PmrB-dependent chemical decorations of the LPS and their role in resistance to antibacterial agents. We analyze the feedback mechanisms that modulate the activity and thus output of the PmrA/PmrB system, dictating when, where, and to what extent bacteria modify their LPS. Finally, we explore the qualitative and quantitative differences in gene expression outputs resulting from the distinct PmrA/PmrB circuit architectures in closely related bacteria, which may account for their differential survival in various ecological niches.

Indexed as

Anti-Bacterial AgentsBacterial ProteinsGene Expression Regulation, BacterialLipopolysaccharidesSalmonella typhimuriumTranscription FactorsAnti-Bacterial AgentsBacterial ProteinsLipopolysaccharidespmrA protein, BacteriaPmrB protein, bacteriaTranscription Factors

Identifiers

PMID23799815
PMCPMC8381567

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.